Four-year results of the platinum randomized trial: can stent metal alloy composition and design affect late clinical outcomes?
Journal of the American College of Cardiology(2014)
Abstract
In the PLATINUM randomized controlled trial, the PROMUS Element Everolimus Eluting Stent (PtCr-EES) was non-inferior to the cobalt chromium PROMUS/XIENCE V EES (CoCr-EES) for the primary endpoint of target lesion failure (TLF) at 1 year. Although the stents have similar polymer, drug and drug
MoreTranslated text
Key words
stent metal,platinum randomized trial,late clinical outcomes,clinical outcomes,randomized trial,four-year
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined